Spectrum of amyloid-related imaging abnormalities associated with aducanumab treatment: a case series report.
BMC neurology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAntibodies, Monoclonal, HumanizedFemaleMagnetic Resonance ImagingMaleAgedAlzheimer DiseaseBrainMiddle AgedAged, 80 and overARIA-E (vasogenic edema)ARIA-H (microhemorrhage or superficial siderosis)AducanumabAmyloid-related imaging abnormalities (ARIA)Case series reportMagnetic resonance imagingClinical Trials, Phase III as Topic
Come citare questo studio
Alireza Atri, Gioacchino G Curiale, Paul Aisen, Jerome Barakos, Derk Purcell, Luc Bracoud, Samantha Budd Haeberlein, Christina Grassi, Richard Hughes, Karen Smirnakis. (2026). Spectrum of amyloid-related imaging abnormalities associated with aducanumab treatment: a case series report.. BMC neurology. DOI: 10.1186/s12883-026-05097-9
Consulta la pubblicazione originale ↗